메뉴 건너뛰기




Volumn 35, Issue 6, 2009, Pages 640-650

Intravesical therapy for urothelial carcinoma of the urinary bladder: A critical review

Author keywords

Administration; Antineoplastic agents; Intravesical; Local; Mycobacterium bovis; Neoplasm recurrence; Urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; IMMUNOLOGICAL ADJUVANT;

EID: 77949530141     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382009000600002     Document Type: Article
Times cited : (21)

References (70)
  • 1
    • 59249101715 scopus 로고    scopus 로고
    • The global burden of urinary bladder cancer
    • Parkin DM: The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl. 2008; 218: 12-20.
    • (2008) Scand J Urol Nephrol Suppl , vol.218 , pp. 12-20
    • Parkin, D.M.1
  • 2
    • 30044441045 scopus 로고    scopus 로고
    • Bladder cancer: epidemiology, staging and grading, and diagnosis
    • Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al.: Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005; 66: 4-34.
    • (2005) Urology , vol.66 , pp. 4-34
    • Kirkali, Z.1    Chan, T.2    Manoharan, M.3    Algaba, F.4    Busch, C.5    Cheng, L.6
  • 3
    • 34547608288 scopus 로고    scopus 로고
    • Natural history, recurrence, and progression in superficial bladder cancer
    • Sylvester RJ: Natural history, recurrence, and progression in superficial bladder cancer. Scientific World Journal. 2006; 6: 2617-25.
    • (2006) Scientific World Journal , vol.6 , pp. 2617-2625
    • Sylvester, R.J.1
  • 4
    • 0030002747 scopus 로고    scopus 로고
    • A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer
    • discussion 1940-1
    • Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MK, et al.: A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol. 1996; 156: 1934-40, discussion 1940-1.
    • (1996) J Urol , vol.156 , pp. 1934-1940
    • Pawinski, A.1    Sylvester, R.2    Kurth, K.H.3    Bouffioux, C.4    van der Meijden, A.5    Parmar, M.K.6
  • 5
    • 0024306979 scopus 로고
    • History of BCG and its substrains
    • Crispen R: History of BCG and its substrains. Prog Clin Biol Res. 1989; 310: 35-50.
    • (1989) Prog Clin Biol Res , vol.310 , pp. 35-50
    • Crispen, R.1
  • 7
    • 0014825236 scopus 로고
    • Immunological factors which influence response to immunotherapy in malignant melanoma
    • discussion 163-4
    • Morton D, Eilber FR, Malmgren RA, Wood WC: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery. 1970; 68: 158-63; discussion 163-4.
    • (1970) Surgery , vol.68 , pp. 158-163
    • Morton, D.1    Eilber, F.R.2    Malmgren, R.A.3    Wood, W.C.4
  • 8
    • 0015374035 scopus 로고
    • Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis
    • Zbar B, Bernstein ID, Bartlett GL, Hanna MG Jr, Rapp HJ: Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst. 1972; 49: 119-30.
    • (1972) J Natl Cancer Inst , vol.49 , pp. 119-130
    • Zbar, B.1    Bernstein, I.D.2    Bartlett, G.L.3    Hanna M.G., Jr.4    Rapp, H.J.5
  • 9
    • 0013878104 scopus 로고
    • Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder
    • Coe JE, Feldman JD: Extracutaneous delayed hypersensitivity, particularly in the guinea-pig bladder. Immunology. 1966; 10: 127-36.
    • (1966) Immunology , vol.10 , pp. 127-136
    • Coe, J.E.1    Feldman, J.D.2
  • 10
    • 0017130525 scopus 로고
    • Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors
    • Morales A, Eidinger D, Bruce AW: Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976; 116: 180-3.
    • (1976) J Urol , vol.116 , pp. 180-183
    • Morales, A.1    Eidinger, D.2    Bruce, A.W.3
  • 11
    • 0021843932 scopus 로고
    • Bacillus Calmette-Guerin immunotherapy for bladder cancer
    • Lamm DL: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J Urol. 1985; 134: 40-7.
    • (1985) J Urol , vol.134 , pp. 40-47
    • Lamm, D.L.1
  • 12
    • 0023001309 scopus 로고
    • A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study
    • Mori K, Lamm DL, Crawford ED: A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study. Urol Int. 1986; 41: 254-9.
    • (1986) Urol Int , vol.41 , pp. 254-259
    • Mori, K.1    Lamm, D.L.2    Crawford, E.D.3
  • 13
    • 0020684282 scopus 로고
    • Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder
    • Herr HW, Pinsky CM, Whitmore WF Jr, Oettgen HF, Melamed MR: Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Cancer. 1983; 51: 1323-6.
    • (1983) Cancer , vol.51 , pp. 1323-1326
    • Herr, H.W.1    Pinsky, C.M.2    Whitmore W.F., Jr.3    Oettgen, H.F.4    Melamed, M.R.5
  • 15
    • 0036765909 scopus 로고    scopus 로고
    • Treatment of patients with superficial bladder cancer stratified by risk groups treated with lyophilized Moreau-Rio de Janeiro BCG strain
    • discussion 435-6
    • Fonseca FP, Bachega W Jr, Zequi SC, Sarkis AS, Guimaraes G, Priante AV, et al.: Treatment of patients with superficial bladder cancer stratified by risk groups treated with lyophilized Moreau-Rio de Janeiro BCG strain. Int Braz J Urol. 2002; 28: 426-35; discussion 435-6.
    • (2002) Int Braz J Urol , vol.28 , pp. 426-435
    • Fonseca, F.P.1    Bachega W., Jr.2    Zequi, S.C.3    Sarkis, A.S.4    Guimaraes, G.5    Priante, A.V.6
  • 16
    • 44649146617 scopus 로고    scopus 로고
    • Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study
    • Yoneyama T, Ohyama C, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, et al.: Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study. Urology. 2008; 71: 1161-5.
    • (2008) Urology , vol.71 , pp. 1161-1165
    • Yoneyama, T.1    Ohyama, C.2    Imai, A.3    Ishimura, H.4    Hagisawa, S.5    Iwabuchi, I.6
  • 17
    • 0027419141 scopus 로고
    • Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule
    • Melekos MD, Chionis H, Pantazakos A, Fokaefs E, Paranychianakis G, Dauaher H: Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule. J Urol. 1993; 149: 744-8.
    • (1993) J Urol , vol.149 , pp. 744-748
    • Melekos, M.D.1    Chionis, H.2    Pantazakos, A.3    Fokaefs, E.4    Paranychianakis, G.5    Dauaher, H.6
  • 18
    • 9444281414 scopus 로고    scopus 로고
    • A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics
    • Krege S, Giani G, Meyer R, Otto T, Rübben H: A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics. J Urol. 1996; 156: 962-6.
    • (1996) J Urol , vol.156 , pp. 962-966
    • Krege, S.1    Giani, G.2    Meyer, R.3    Otto, T.4    Rübben, H.5
  • 19
    • 34248595861 scopus 로고    scopus 로고
    • Randomized prospective study comparing long-term intravesical instillation of BCG after transurethral resection and transurethral resection alone in patients with superficial bladder cancer
    • Iantorno R, Nicolai M, Mastroprimiano G, Ballone E, Passamonti M, Cipollone G, et al.: Randomized prospective study comparing long-term intravesical instillation of BCG after transurethral resection and transurethral resection alone in patients with superficial bladder cancer. J Urol. 1999; 161(Suppl): 284.
    • (1999) J Urol , vol.161 , Issue.SUPPL , pp. 284
    • Iantorno, R.1    Nicolai, M.2    Mastroprimiano, G.3    Ballone, E.4    Passamonti, M.5    Cipollone, G.6
  • 20
    • 0026725003 scopus 로고
    • Long-term results of intravesical therapy for superficial bladder cancer
    • Lamm DL: Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am. 1992; 19: 573-80.
    • (1992) Urol Clin North Am , vol.19 , pp. 573-580
    • Lamm, D.L.1
  • 23
    • 0027172391 scopus 로고
    • Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study
    • Witjes JA, Fransen MP, van der Meijden AP, Doesburg WH, Debruyne FM: Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. Urol Int. 1993; 51: 67-72.
    • (1993) Urol Int , vol.51 , pp. 67-72
    • Witjes, J.A.1    Fransen, M.P.2    van der Meijden, A.P.3    Doesburg, W.H.4    Debruyne, F.M.5
  • 24
    • 0036837453 scopus 로고    scopus 로고
    • Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials
    • Sylvester RJ, van der Meijden AP, Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002; 168: 1964-70.
    • (2002) J Urol , vol.168 , pp. 1964-1970
    • Sylvester, R.J.1    van der Meijden, A.P.2    Lamm, D.L.3
  • 25
    • 33744513525 scopus 로고    scopus 로고
    • Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
    • Han RF, Pan JG: Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006; 67: 1216-23.
    • (2006) Urology , vol.67 , pp. 1216-1223
    • Han, R.F.1    Pan, J.G.2
  • 26
    • 33745513016 scopus 로고    scopus 로고
    • Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer
    • National BCG-Interferon Phase 2 Investigator Group
    • Joudi FN, Smith BJ, O'Donnell MA; National BCG-Interferon Phase 2 Investigator Group: Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer. Urol Oncol. 2006; 24: 344-8.
    • (2006) Urol Oncol , vol.24 , pp. 344-348
    • Joudi, F.N.1    Smith, B.J.2    O'Donnell, M.A.3
  • 27
    • 33845346443 scopus 로고    scopus 로고
    • Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    • discussion 79
    • Herr HW, Donat SM, Dalbagni G: Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol. 2007; 177: 75-9; discussion 79.
    • (2007) J Urol , vol.177 , pp. 75-79
    • Herr, H.W.1    Donat, S.M.2    Dalbagni, G.3
  • 28
    • 55649120015 scopus 로고    scopus 로고
    • Is maintenance Bacillus Calmette-Guérin really necessary?
    • Herr HW: Is maintenance Bacillus Calmette-Guérin really necessary? Eur Urol. 2008; 54: 971-3.
    • (2008) Eur Urol , vol.54 , pp. 971-973
    • Herr, H.W.1
  • 29
    • 20444492338 scopus 로고    scopus 로고
    • Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
    • discussion 91-2
    • Sylvester RJ, van der Meijden AP, Witjes JA, Kurth K: Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol. 2005; 174: 86-91; discussion 91-2.
    • (2005) J Urol , vol.174 , pp. 86-91
    • Sylvester, R.J.1    van der Meijden, A.P.2    Witjes, J.A.3    Kurth, K.4
  • 30
    • 0034105381 scopus 로고    scopus 로고
    • Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study
    • Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al.: Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol. 2000; 163: 1124-9.
    • (2000) J Urol , vol.163 , pp. 1124-1129
    • Lamm, D.L.1    Blumenstein, B.A.2    Crissman, J.D.3    Montie, J.E.4    Gottesman, J.E.5    Lowe, B.A.6
  • 31
    • 0023228973 scopus 로고
    • Toxicity of intravesical BCG and its management in patients with superficial bladder tumors
    • Orihuela E, Herr HW, Pinsky CM, Whitmore WF Jr: Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer. 1987; 60: 326-33.
    • (1987) Cancer , vol.60 , pp. 326-333
    • Orihuela, E.1    Herr, H.W.2    Pinsky, C.M.3    Whitmore W.F., Jr.4
  • 32
    • 0030111245 scopus 로고    scopus 로고
    • Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group Study
    • discussion 101
    • Berry DL, Blumenstein BA, Magyary DL, Lamm DL, Crawford ED: Local toxicity patterns associated with intravesical bacillus Calmette-Guérin: a Southwest Oncology Group Study. Int J Urol. 1996; 3: 98-100; discussion 101.
    • (1996) Int J Urol , vol.3 , pp. 98-100
    • Berry, D.L.1    Blumenstein, B.A.2    Magyary, D.L.3    Lamm, D.L.4    Crawford, E.D.5
  • 33
    • 0024329488 scopus 로고
    • Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications
    • Lamm DL, Steg A, Boccon-Gibod L, Morales A, Hanna MG Jr, Pagano F, et al.: Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res. 1989; 310: 335-55.
    • (1989) Prog Clin Biol Res , vol.310 , pp. 335-355
    • Lamm, D.L.1    Steg, A.2    Boccon-Gibod, L.3    Morales, A.4    Hanna M.G., Jr.5    Pagano, F.6
  • 34
    • 0024331254 scopus 로고
    • Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer
    • Steg A, Leleu C, Debré B, Boccon-Gibod L, Sicard D: Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Prog Clin Biol Res. 1989; 310: 325-34.
    • (1989) Prog Clin Biol Res , vol.310 , pp. 325-334
    • Steg, A.1    Leleu, C.2    Debré, B.3    Boccon-Gibod, L.4    Sicard, D.5
  • 36
    • 24944548274 scopus 로고    scopus 로고
    • Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial
    • Martínez-Piñeiro JA, Martínez-Piñeiro L, Solsona E, Rodríguez RH, Gómez JM, Martín MG, et al.: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. J Urol. 2005; 174: 1242-7.
    • (2005) J Urol , vol.174 , pp. 1242-1247
    • Martínez-Piñeiro, J.A.1    Martínez-Piñeiro, L.2    Solsona, E.3    Rodríguez, R.H.4    Gómez, J.M.5    Martín, M.G.6
  • 37
    • 0034960010 scopus 로고    scopus 로고
    • Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in urothelial bladder cancer
    • Nilsson S, Ragnhammar P, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol. 2001; 40: 371-90.
    • (2001) Acta Oncol , vol.40 , pp. 371-390
    • Nilsson, S.1    Ragnhammar, P.2    Glimelius, B.3    Nygren, P.4
  • 38
    • 0026780422 scopus 로고
    • Complications of intravesical chemotherapy
    • Thrasher JB, Crawford ED: Complications of intravesical chemotherapy. Urol Clin North Am. 1992; 19: 529-39.
    • (1992) Urol Clin North Am , vol.19 , pp. 529-539
    • Thrasher, J.B.1    Crawford, E.D.2
  • 39
    • 0031883090 scopus 로고    scopus 로고
    • Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine
    • Gao X, Au JL, Badalament RA, Wientjes MG: Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Clin Cancer Res. 1998; 4: 139-43.
    • (1998) Clin Cancer Res , vol.4 , pp. 139-143
    • Gao, X.1    Au, J.L.2    Badalament, R.A.3    Wientjes, M.G.4
  • 41
    • 0028946881 scopus 로고
    • Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder
    • Lamm DL, Riggs DR, Traynelis CL, Nseyo UO: Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol. 1995; 153: 1444-50.
    • (1995) J Urol , vol.153 , pp. 1444-1450
    • Lamm, D.L.1    Riggs, D.R.2    Traynelis, C.L.3    Nseyo, U.O.4
  • 42
    • 0033863026 scopus 로고    scopus 로고
    • Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials
    • Huncharek M, Geschwind JF, Witherspoon B, McGarry R, Adcock D: Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials. J Clin Epidemiol. 2000; 53: 676-80.
    • (2000) J Clin Epidemiol , vol.53 , pp. 676-680
    • Huncharek, M.1    Geschwind, J.F.2    Witherspoon, B.3    McGarry, R.4    Adcock, D.5
  • 43
    • 0035064519 scopus 로고    scopus 로고
    • Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis
    • Huncharek M, McGarry R, Kupelnick B: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res. 2001; 21: 765-9.
    • (2001) Anticancer Res , vol.21 , pp. 765-769
    • Huncharek, M.1    McGarry, R.2    Kupelnick, B.3
  • 44
    • 36448950859 scopus 로고    scopus 로고
    • Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results
    • Witjes JA, Hendricksen K: Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol. 2008; 53: 45-52.
    • (2008) Eur Urol , vol.53 , pp. 45-52
    • Witjes, J.A.1    Hendricksen, K.2
  • 45
    • 2442581163 scopus 로고    scopus 로고
    • A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials
    • Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004; 171: 2186-90.
    • (2004) J Urol , vol.171 , pp. 2186-2190
    • Sylvester, R.J.1    Oosterlinck, W.2    van der Meijden, A.P.3
  • 46
    • 33745527134 scopus 로고    scopus 로고
    • Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder
    • Dalbagni G, Russo P, Bochner B, Ben-Porat L, Sheinfeld J, Sogani P, et al.: Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. J Clin Oncol. 2006; 24: 2729-34.
    • (2006) J Clin Oncol , vol.24 , pp. 2729-2734
    • Dalbagni, G.1    Russo, P.2    Bochner, B.3    Ben-Porat, L.4    Sheinfeld, J.5    Sogani, P.6
  • 47
    • 0026004545 scopus 로고
    • A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder
    • Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, et al.: A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991; 325: 1205-9.
    • (1991) N Engl J Med , vol.325 , pp. 1205-1209
    • Lamm, D.L.1    Blumenstein, B.A.2    Crawford, E.D.3    Montie, J.E.4    Scardino, P.5    Grossman, H.B.6
  • 48
    • 0037213844 scopus 로고    scopus 로고
    • Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity
    • Böhle A, Jocham D, Bock PR: Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol. 2003; 169: 90-5.
    • (2003) J Urol , vol.169 , pp. 90-95
    • Böhle, A.1    Jocham, D.2    Bock, P.R.3
  • 49
    • 1642306191 scopus 로고    scopus 로고
    • Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials
    • Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD: Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int. 2004; 93: 485-90.
    • (2004) BJU Int , vol.93 , pp. 485-490
    • Shelley, M.D.1    Wilt, T.J.2    Court, J.3    Coles, B.4    Kynaston, H.5    Mason, M.D.6
  • 50
    • 1842789737 scopus 로고    scopus 로고
    • Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
    • discussion 686-7
    • Böhle A, Bock PR: Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology. 2004; 63: 682-6; discussion 686-7.
    • (2004) Urology , vol.63 , pp. 682-686
    • Böhle, A.1    Bock, P.R.2
  • 51
    • 36049006136 scopus 로고    scopus 로고
    • Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update
    • Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al.: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. Urol. 2007; 178: 2314-30.
    • (2007) Urol , vol.178 , pp. 2314-2330
    • Hall, M.C.1    Chang, S.S.2    Dalbagni, G.3    Pruthi, R.S.4    Seigne, J.D.5    Skinner, E.C.6
  • 52
    • 0023387530 scopus 로고
    • Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial
    • Hudson MA, Ratliff TL, Gillen DP, Haaff EO, Dresner SM, Catalona WJ: Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial. J Urol. 1987; 138: 295-8.
    • (1987) J Urol , vol.138 , pp. 295-298
    • Hudson, M.A.1    Ratliff, T.L.2    Gillen, D.P.3    Haaff, E.O.4    Dresner, S.M.5    Catalona, W.J.6
  • 53
    • 0023102588 scopus 로고
    • A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer
    • Badalament RA, Herr HW, Wong GY, Gnecco C, Pinsky CM, Whitmore WF Jr, et al.: A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol. 1987; 5: 441-9.
    • (1987) J Clin Oncol , vol.5 , pp. 441-449
    • Badalament, R.A.1    Herr, H.W.2    Wong, G.Y.3    Gnecco, C.4    Pinsky, C.M.5    Whitmore W.F., Jr.6
  • 54
    • 0035047153 scopus 로고    scopus 로고
    • Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors
    • Palou J, Laguna P, Millán-Rodríguez F, Hall RR, Salvador-Bayarri J, Vicente-Rodríguez J: Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol. 2001; 165: 1488-91.
    • (2001) J Urol , vol.165 , pp. 1488-1491
    • Palou, J.1    Laguna, P.2    Millán-Rodríguez, F.3    Hall, R.R.4    Salvador-Bayarri, J.5    Vicente-Rodríguez, J.6
  • 55
    • 67649431728 scopus 로고    scopus 로고
    • An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin-C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer
    • discussion 258-9
    • Malmström PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, et al.: An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin-C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol. 2009; 56: 257-8; discussion 258-9.
    • (2009) Eur Urol , vol.56 , pp. 257-258
    • Malmström, P.U.1    Sylvester, R.J.2    Crawford, D.E.3    Friedrich, M.4    Krege, S.5    Rintala, E.6
  • 56
    • 0025335684 scopus 로고
    • Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients
    • discussion 71-2
    • Huland H, Klöppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, et al.: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J Urol. 1990; 144: 68-71; discussion 71-2.
    • (1990) J Urol , vol.144 , pp. 68-71
    • Huland, H.1    Klöppel, G.2    Feddersen, I.3    Otto, U.4    Brachmann, W.5    Hubmann, H.6
  • 57
    • 0028909214 scopus 로고
    • Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group
    • Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M, et al.: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol. 1995; 153: 934-41.
    • (1995) J Urol , vol.153 , pp. 934-941
    • Bouffioux, C.1    Kurth, K.H.2    Bono, A.3    Oosterlinck, W.4    Kruger, C.B.5    De Pauw, M.6
  • 58
    • 6844252900 scopus 로고    scopus 로고
    • A randomized study of shortversus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group
    • discussion 289
    • Okamura K, Kinukawa T, Tsumura Y, Otani T, Itoh H, Kobayashi H, et al.: A randomized study of shortversus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group. Eur Urol. 1998; 33: 285-8; discussion 289.
    • (1998) Eur Urol , vol.33 , pp. 285-288
    • Okamura, K.1    Kinukawa, T.2    Tsumura, Y.3    Otani, T.4    Itoh, H.5    Kobayashi, H.6
  • 59
    • 0348109412 scopus 로고    scopus 로고
    • A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder
    • Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S: A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. J Urol. 2004; 171: 153-7.
    • (2004) J Urol , vol.171 , pp. 153-157
    • Koga, H.1    Kuroiwa, K.2    Yamaguchi, A.3    Osada, Y.4    Tsuneyoshi, M.5    Naito, S.6
  • 60
    • 18144424943 scopus 로고    scopus 로고
    • Long term prophylaxis with mitomycin C (MMC) further reduces tumor recurrence compared to short term prophylaxis with MMC or bacillus Calmette-Guerin (BCG)
    • [Abstract]
    • Conrad S, Friedrich MG, Schwaibold H, Pichlmeier U, Schildt K, Wolf N: Long term prophylaxis with mitomycin C (MMC) further reduces tumor recurrence compared to short term prophylaxis with MMC or bacillus Calmette-Guerin (BCG). J Urol. 2004; 171: [Abstract] 271.
    • (2004) J Urol , vol.171 , pp. 271
    • Conrad, S.1    Friedrich, M.G.2    Schwaibold, H.3    Pichlmeier, U.4    Schildt, K.5    Wolf, N.6
  • 61
    • 34548324433 scopus 로고    scopus 로고
    • Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma
    • Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Eur Urol. 2007; 52: 1123-29.
    • (2007) Eur Urol , vol.52 , pp. 1123-1129
    • Friedrich, M.G.1    Pichlmeier, U.2    Schwaibold, H.3    Conrad, S.4    Huland, H.5
  • 62
    • 0030914050 scopus 로고    scopus 로고
    • The treated natural history of high risk superficial bladder cancer: 15-year outcome
    • Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol. 1997; 158: 62-7.
    • (1997) J Urol , vol.158 , pp. 62-67
    • Cookson, M.S.1    Herr, H.W.2    Zhang, Z.F.3    Soloway, S.4    Sogani, P.C.5    Fair, W.R.6
  • 63
    • 0141460505 scopus 로고    scopus 로고
    • Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial
    • EORTC Genito-Urinary Tract Cancer Group
    • van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group: Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol. 2003; 44: 429-34.
    • (2003) Eur Urol , vol.44 , pp. 429-434
    • van der Meijden, A.P.1    Sylvester, R.J.2    Oosterlinck, W.3    Hoeltl, W.4    Bono, A.V.5
  • 64
    • 0037404879 scopus 로고    scopus 로고
    • Defining bacillus Calmette-Guerin refractory superficial bladder tumors
    • Herr HW, Dalbagni G: Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol. 2003; 169: 1706-8.
    • (2003) J Urol , vol.169 , pp. 1706-1708
    • Herr, H.W.1    Dalbagni, G.2
  • 65
    • 0037422679 scopus 로고    scopus 로고
    • Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect
    • Luo Y, Chen X, O'Donnell MA: Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect. Cytokine. 2003; 21: 17-26.
    • (2003) Cytokine , vol.21 , pp. 17-26
    • Luo, Y.1    Chen, X.2    O'Donnell, M.A.3
  • 66
    • 72449169235 scopus 로고    scopus 로고
    • The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer()
    • [Epub ahead of print]
    • Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, et al.: The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer(). Urol Oncol. 2009; 7. [Epub ahead of print]
    • (2009) Urol Oncol , pp. 7
    • Andrade, P.M.1    Chade, D.C.2    Borra, R.C.3    Nascimento, I.P.4    Villanova, F.E.5    Leite, L.C.6
  • 67
    • 62149100674 scopus 로고    scopus 로고
    • Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model
    • Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, Andrade E, et al.: Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model. J Exp Clin Cancer Res. 2008; 27: 78.
    • (2008) J Exp Clin Cancer Res , vol.27 , pp. 78
    • Chade, D.C.1    Borra, R.C.2    Nascimento, I.P.3    Villanova, F.E.4    Leite, L.C.5    Andrade, E.6
  • 68
    • 68549123471 scopus 로고    scopus 로고
    • Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro
    • [Epub ahead of print]
    • Liu W, O'Donnell MA, Chen X, Han R, Luo Y: Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro. Cancer Immunol Immunother. 2009; 13. [Epub ahead of print]
    • (2009) Cancer Immunol Immunother , pp. 13
    • Liu, W.1    O'Donnell, M.A.2    Chen, X.3    Han, R.4    Luo, Y.5
  • 69
    • 59349116084 scopus 로고    scopus 로고
    • Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed
    • Morales A, Phadke K, Steinhoff G: Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed. J Urol. 2009; 181: 1040-5.
    • (2009) J Urol , vol.181 , pp. 1040-1045
    • Morales, A.1    Phadke, K.2    Steinhoff, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.